Breast Carcinoma in Situ, also known as carcinoma in situ of breast, is related to comedo carcinoma and lobular neoplasia. An important gene associated with Breast Carcinoma in Situ is ERBB2 (Erb-B2 Receptor Tyrosine Kinase 2), and among its related pathways/superpathways are Infectious disease and GPCR Pathway. The drugs Oxybutynin and Paclitaxel have been mentioned in the context of this disorder. Affiliated tissues include breast and skin, and related phenotypes are growth/size/body region and normal